107 related articles for article (PubMed ID: 38942533)
1. Drug repurposing for bacterial infections.
Ilyas M; Latif MS; Gul A; Babar MM; Rajadas J
Prog Mol Biol Transl Sci; 2024; 207():1-21. PubMed ID: 38942533
[TBL] [Abstract][Full Text] [Related]
2. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
Konreddy AK; Rani GU; Lee K; Choi Y
Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
[TBL] [Abstract][Full Text] [Related]
4. Anthelmintic Drugs for Repurposing against Gram-Negative Bacilli Infections.
Canturri AM; Smani Y
Curr Med Chem; 2022; 30(1):59-71. PubMed ID: 35838224
[TBL] [Abstract][Full Text] [Related]
5. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of antibiotics to combat antimicrobial resistance.
Dubey KK; Indu ; Sharma M
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000168. PubMed ID: 32776618
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics.
Liu Y; Lu Y; Xu Z; Ma X; Chen X; Liu W
Drug Discov Today; 2022 Jul; 27(7):1961-1973. PubMed ID: 35192926
[TBL] [Abstract][Full Text] [Related]
8. Modulating the antibacterial effect of the existing antibiotics along with repurposing drug metformin.
Hossain S; Rafi RH; Ripa FA; Khan MRI; Hosen ME; Molla MKI; Faruqe MO; Al-Bari MAA; Das S
Arch Microbiol; 2024 Mar; 206(4):190. PubMed ID: 38519821
[TBL] [Abstract][Full Text] [Related]
9. Repurposed drug candidates for antituberculosis therapy.
An Q; Li C; Chen Y; Deng Y; Yang T; Luo Y
Eur J Med Chem; 2020 Apr; 192():112175. PubMed ID: 32126450
[TBL] [Abstract][Full Text] [Related]
10. Repurposing of gallium-based drugs for antibacterial therapy.
Bonchi C; Imperi F; Minandri F; Visca P; Frangipani E
Biofactors; 2014; 40(3):303-12. PubMed ID: 24532037
[TBL] [Abstract][Full Text] [Related]
11. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
12. Repurposing of Auranofin Against Bacterial Infections: An In silico and In vitro Study.
Sharma N; Singh A; Sharma R; Kumar A
Curr Comput Aided Drug Des; 2021; 17(5):687-701. PubMed ID: 32679020
[TBL] [Abstract][Full Text] [Related]
13. Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
Thangamani S; Mohammad H; Abushahba MF; Sobreira TJ; Seleem MN
Int J Antimicrob Agents; 2016 Mar; 47(3):195-201. PubMed ID: 26895605
[TBL] [Abstract][Full Text] [Related]
14. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
[TBL] [Abstract][Full Text] [Related]
15. The first wide-scale drug repurposing screen using the Prestwick Chemical Library (1200 bioactive molecules) against Neisseria gonorrhoeae identifies high in vitro activity of auranofin and many additional drugs.
Foerster S; Gustafsson TN; Brochado AR; Desilvestro V; Typas A; Unemo M
APMIS; 2020 Mar; 128(3):242-250. PubMed ID: 31811739
[TBL] [Abstract][Full Text] [Related]
16. Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections.
Younis W; Thangamani S; Seleem MN
Curr Pharm Des; 2015; 21(28):4106-11. PubMed ID: 25961308
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing for the treatment of staphylococcal infections.
Thangamani S; Mohammad H; Younis W; Seleem MN
Curr Pharm Des; 2015; 21(16):2089-100. PubMed ID: 25760334
[TBL] [Abstract][Full Text] [Related]
18. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
[TBL] [Abstract][Full Text] [Related]
19. Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis.
Di Bonaventura G; Lupetti V; Di Giulio A; Muzzi M; Piccirilli A; Cariani L; Pompilio A
Microbiol Spectr; 2023 Aug; 11(4):e0035223. PubMed ID: 37306577
[TBL] [Abstract][Full Text] [Related]
20. Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria.
Yu Y; Zhao H; Lin J; Li Z; Tian G; Yang YY; Yuan P; Ding X
Int J Antimicrob Agents; 2022 May; 59(5):106582. PubMed ID: 35378227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]